{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:17:14Z","timestamp":1789168634501,"version":"build-2803163510"},"reference-count":18,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100016156","name":"U.S. Army Medical Research and Development Command","doi-asserted-by":"publisher","award":["B_018_2020"],"award-info":[{"award-number":["B_018_2020"]}],"id":[{"id":"10.13039\/100016156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Plasma has been used as an efficient resuscitation fluid to improve prehospital survival from hemorrhagic shock. The 25% albumin (25% ALB, w\/v in aqueous diluent) is a hyperoncotic fluid, and we hypothesize that it can be used as a lower\u2010volume alternative to plasma in hypovolemic shock.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>Isoflurane\u2010anesthetized Sprague\u2010Dawley rats were subjected to a lethal decompensated hemorrhagic shock via removing 65% estimated blood volume (EBV, calculated by 6% body weight (gram)\u2009+\u20090.77\u2009mL) of blood within 20\u2009min. At 20\u2009min post\u2010hemorrhage, rats randomly received plasma (20% EBV), 25% ALB (4% EBV), or respective vehicles, followed by fresh whole blood (FWB, 20% EBV) at 1\u2009h post\u2010hemorrhage. The outcome was also compared between plasma and 25% ALB without FWB resuscitation in a separate experiment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>20% EBV of plasma or 4% EBV of 25% ALB led to 100% survival at 60\u2009min from the start of hemorrhage, compared to zero survival without treatment. Survival was maintained at least 4\u2009h following limited resuscitation, with or without FWB at 1\u2009h post\u2010hemorrhage. The lack of fibrinogen in 25% ALB was notable and compromised the hemostatic outcome as compared to using plasma, which was partially restored by FWB resuscitation with the reduction in prothrombin time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The current study indicates that 25% ALB enhances survival and maintains hemodynamics at only one\u2010fifth the volume of plasma. The results also suggest that 25% ALB requires hemostatic agents or subsequent blood products to counteract the hemostatic deficiency caused by hemodilution.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/trf.70344","type":"journal-article","created":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:05:25Z","timestamp":1788170725000},"page":"1747-1757","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Administration of 25% albumin improves prehospital survivability in a preclinical rat model of decompensated hemorrhagic shock"],"prefix":"10.1111","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1024-0900","authenticated-orcid":false,"given":"Xiaowu","family":"Wu","sequence":"first","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffani C.","family":"Chance","sequence":"additional","affiliation":[{"name":"Department of Health and Human Services, Center for Devices and Radiological Health Food and Drug Administration  Silver Spring Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin C.","family":"Sunsong","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maegan T.","family":"French","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery D.","family":"Keesee","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Botts","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica M.","family":"Lopez","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9958-9115","authenticated-orcid":false,"given":"Michael A.","family":"Meledeo","sequence":"additional","affiliation":[{"name":"Blood and Shock Resuscitation United States Army Institute of Surgical Research  Fort Sam Houston Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,31]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e3182755dcc"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0b013e318221147b"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000000292"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.55460\/QT3B-XK5B"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2015.3104"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1305480"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1097\/TA.0000000000001091"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.72351"},{"issue":"1","key":"e_1_2_12_10_1","first-page":"72","article-title":"Blood volume in the rat","volume":"26","author":"Lee HB","year":"1985","journal-title":"J Nucl Med"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-53945-w"},{"key":"e_1_2_12_12_1","article-title":"Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function","volume":"1","author":"Dart AB","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"e_1_2_12_13_1","article-title":"Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function","volume":"2013","author":"Mutter TC","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1757-7241-21-86"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.430"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamasurg.2019.5085"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1802345"},{"issue":"7153","key":"e_1_2_12_18_1","first-page":"235","article-title":"Human albumin administration in critically ill patients: systematic review of randomised controlled trials","volume":"317","author":"Cochrane Injuries Group Albumin R","year":"1998","journal-title":"BMJ"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc6812"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/trf.70344","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.70344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:51:25Z","timestamp":1789167085000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.70344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,31]]},"references-count":18,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1111\/trf.70344"],"URL":"https:\/\/doi.org\/10.1111\/trf.70344","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"value":"0041-1132","type":"print"},{"value":"1537-2995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,31]]},"assertion":[{"value":"2025-12-01","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-31","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}